Pharmapick (blue line) outperforms unit dose robots (red line) in cost-effectiveness, flexibility, safety, space usability, and staff productivity. With a lower initial investment and Total Cost of Ownership (TCO) over ten years, Pharmapick provides significant long-term benefits.

While unit dose robots excel in automation and inventory management, their higher costs and limited flexibility make them less adaptable, positioning Pharmapick as the more versatile and cost-effective solution.